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Abstract: The respiratory system represents the main gateway for nanoparticles’ entry into the human
body. Although there is a myriad of engineered nanoparticles, carbon nanoparticles/nanotubes
(CNPs/CNTs) have received much attention mainly due to their light weight, very high surface
area, durability, and their diverse applications. Since their discovery and manufacture over two
decades ago, much has been learned about nanoparticles’ interactions with diverse biological system
models. In particular, the respiratory system has been of great interest because various natural and
man-made fibrous particles are known to be responsible for chronic and debilitating lung diseases. In
this review, we present up-to-date the literature regarding the effects of CNTs or carbon nanofibers
(CNFs) on the human respiratory system with respect to respiratory toxicity pathways and associated
pathologies. This article is intended to emphasize the potentially dangerous effects to the human
respiratory system if inadequate measures are used in the manufacture, handling, and preparation
and applications of CNP or CNP-based products.
Keywords: CNF; CNT; respiratory pathology; toxicological pathways; exposure levels

1. Introduction
Carbon nanomaterials, mainly represented by carbon nanoparticles or carbon nanotubes
(CNPs/CNTs), and carbon nanofibers (CNFs), have captured the interest of the scientific community
for more than two decades since the discovery of the first nanometer-sized carbon nanotubes [1].
Carbon nanomaterials have unprecedented potential for a large variety of industrial and biomedical
applications. In industry, carbon-based nanomaterials have potential uses in many applications
ranging from aerospace, construction, automobiles, electronics, and others. In the medical field, carbon
nanomaterials are being considered as contrast agents, chemo-carriers, biological platforms, and
for many other applications [2]. Currently, financial investment in nanotechnology is substantial,
suggesting that an abundance of nano-based products will reach the market in the next few years [3].
While CNTs have been the focus of intense research, another type of carbon-based nanomaterial, CNF,
is becoming increasingly prevalent as a nanomaterial of choice for nanoproducts/nanoscaffolds. CNFs
seem to be a very suitable nanomaterial for biomaterial production. However, their effects on biological
processes are mostly unknown to date. Thus, this review aims to present the current information on
CNPs/CNTs and CNFs effects on the respiratory system.
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2. Are CNT and CNF Structurally Different?
Carbon allotropes are present in a variety of carbon nanostructures including graphene,
amorphous carbon, CNTs, and CNFs. Like CNTs, CNFs are increasingly used in many industrial
applications, particularly, as polymer nanocomposites to provide strength, stiffness, heat resistance,
and durability [4]. CNTs and CNFs belong to the same family, yet both these carbon nanostructures
have distinct features. The physical and chemical properties of CNTs have been comprehensively
presented in numerous reviews [5,6] and will not be discussed in the present review. Single-walled
(SW)-CNTs are more distinct from CNFs, as opposed to multi-walled (MW)-CNTs. SWCNTs are a
single sheet of graphene and, therefore, possess less rigidity and aggregate in bundles, properties
that set them apart from MWCNTs and CNFs. MWCNTs are multiple sheets of graphene arranged
concentrically with diameters between 10 and 150 nm [7]. Structurally, CNFs are layers of graphene
arranged in an axial arrangement that form these carbon nanostructure fibers. CNFs have diameters
ranging from 70 to 200 nm, and lengths of 10 to 100 µm [8]. CNFs may pose different health hazard
implications compared to CNTs due to the differences in structural aspects between CNTs and CNFs;
moreover, these nanostructures are less investigated than CNTs. It is envisioned that CNT and CNF
end-products will dominate many aspects of industry due to their attractive intrinsic properties;
thus, increased human exposure either at the synthesis or end-product is highly possible. Therefore,
understanding the toxicological and pathological effects related to CNTs and CNFs is imperative to
avoid potential respiratory effects such as those observed, for example, with asbestos exposure [5,9,10].
3. CNTs and CNFs as Bio-Scaffold and Bio-Sensor Materials
CNTs and different CNFs nanostructures are being investigated as biomaterial hybrid scaffolds.
The sustainability of CNFs as scaffold materials stems from their fibrous nature, which mimics the
fibrillar structure of extracellular matrix proteins. This nano-fibrillar structure provides a structural
mesh for cell adherence and interactions making CNFs potential nanomaterials for orthopedic
applications and more recently for peripheral nerve regeneration [11,12]. For example, a type of
CNF with a hat-stacked nanostructure (H-CNF) were implanted subcutaneously, and after four weeks
these H-CNF clusters were surrounded by a thin layer of connective tissue suggesting no tissue
toxicity but indeed biocompatibility with surrounding tissue [12]. However, slight inflammation
and the presence of phagocytizing macrophages were noticed at the H-CNF site. These processes
were however considered as part of the wound healing process rather than a toxicological response.
Carbon nanofiber-based thin films and mats have been tested for directed growth of Schwann cells [11].
Schwann cells proliferated when grown on CNF- and carbon-films without apoptosis or reactive
oxygen species (ROS) formation. These results suggest that the fibrous nature of CNF provides suitable
physical guidance for peripheral nerve cell growth, and may open-up new ways for neural tissue
engineering, particularly peripheral nerve regeneration [11].
Cell adherence to CNFs patterned on polymer substrates was evaluated using osteoblast cells.
Khang et al. [13] maintained cultures of osteoblasts for 21 days on matrices patterned with CNFs
and found osteoblast cells to be fully functional with mineral deposition along the CNF patterns.
Price et al. [14] used two types of carbon fiber compacts, conventional carbon and nanometer carbon
fibers, to determine the adhesion of osteoblast cells. Osteoblasts cultured on carbon nanofiber scaffolds
showed selective adherence to nanometer-dimension rough surfaces. These results suggest that
CN-based scaffolds, perhaps due to their nanosize, are the preferred nanomaterials for use in directed
bone growth applications, or for successful orthopedic and dental implants.
MWCNTs have been tested for muscle tissue engineering. Ostrovidov et al. [15] investigated a
hybrid of gelatin and multi-walled fibers for myotube formation and functionality. MWCNTs enhanced
the formation of fully functional myotubes with mechano-transductive properties, suggesting that
MWCNTs may represent a novel scaffold material for skeletal tissue formation.
SWCNTs and MWCNTs have been tested as biosensors for the detection of proteins, nucleic
acids, enzymes, and other biomolecules [16,17]. Carbon nanofibers, just recently, have been used
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for biosensors. For example, vertically aligned carbon nanofibers (VACNFs) seem to be a suitable
material for the fabrication of biosensors for the detection of cardiac troponin [18] or C-reactive
protein (CRP) [19]. Gupta et al. [19] tested a CNF-based biosensor platform for the detection of CRP
and demonstrated that a CNF-sensor could potentially be developed to detect clinically relevant
CRP level with high specificity. Moreover, the applicability of CNF-based biosensors has been
extended to evaluate drug metabolism and inhibition. Xue et al. [20] reported the development
of a CNF-modified film electrode in which the drug metabolizing enzyme, CYP3A4, was physically
adsorbed producing a CYP3A4/CNF-modified film electrode. In comparison with CNT or carbon
black (CB), the CNF-modified film electrode was the most efficient substrate for the physical adsorption
of CYP3A4 onto film. The application of CNF-based film electrodes has the potential to revolutionize
the time and type of drug metabolism screening as well as screening for CYP3A4 inhibitors. CNF
applications have also been extended to phyto-pharmaceutical testing with potential applications in
anticancer phytochemical discovery. Shao et al. [21] developed MWCNT-based nanofibers to which
green tea polyphenols were adsorbed to test green tea antioxidant cancer therapy. The viability of
an array of cell types (e.g., osteoblast, A549, and HepG2) on GTP-bound nanofibers were tested. Of
all tested cells, HepG2 cells were more sensitive to GTP-bound nanofibers compared to osteoblast or
A549 cells, suggesting the appropriateness of carbon-nanofiber platforms for antioxidant-linked cancer
therapy. The applicability of CNF-based biosensors has been tested for the detection of catechol, a
phenolic compound found in pesticides, and other pharmaceuticals [22]. The detection of catechol in
solution was possible with the use of the laccase enzyme immobilized on electrospun CNF (ECNF)
films. The detection limit of catechol in the solution was 0.63 µM within a 2 s response time, an
indicator that such platforms could revolutionize testing for environmental/food chemistry safety.
Another recent application of carbon nanoparticles was the use of CNTs for microRNA (miRNAs)
detection. Li et al. [23] designed MWCNT-based biosensors to which synthetic DNA probes
complementary to miRNAs were immobilized. The hybridization of specific microRNAs was measured
using guanine oxidation signals when a specific microRNA bound to its complementary DNA. Guanine
oxidation was quantified using differential pulse voltammetry. Detection of microRNA expression
using MWCNT-biosensors appears to be simple and cost-effective, given that microRNA are emerging
important regulators of gene expression in plants, animals, and humans. Therefore, determining
microRNA expression levels will provide information that will help to understand how microRNAs
are associated with biological processes and human disease. To validate this method, Li et al. [24] tested
microRNA-24 hybridization to the MWCNT-biosensor, which showed a good sensitivity, selectivity,
and reproducibility. However, hybridization time seemed to play an important role in the detection of
microRNA-24, suggesting that microRNA are susceptible to degradation. Despite this, the authors
were able to obtain an acceptable recovery concentration of microRNA-24.
MWCNTs applications to biological systems, such as skeletal muscle fiber formation on gelatin
nanofibers-MWCNT hybrid scaffolds, have been also investigated. Ostrovidov et al. [15] examined two
concentrations of MWCNT, 0.5 and 5 mg/mL, combined with gelatin (20%) as a scaffold support for
myofiber formation. Addition of MWCNT significantly increased the mechanical strength of gelatin
nanofibers according to Young’s modulus measurements, and provided the necessary frame for C2C12
myoblast cell alignment, an indication for supporting myotube formation. C2C12 cell viability was
not affected when the cells were cultured for two days, and myotube length increased with increasing
MWCNT concentrations on gelatin nanofibers. Moreover, the gelatin-MWCNT nanofiber-guided
myotubes exhibited contractibility under electrical stimulation that increased with increasing MWCNTs
concentrations. These results suggest that gelatin-MWCNT hybrid scaffolds may be useful for skeletal
muscle formation which could be applicable for muscle regeneration in skeletal muscle diseases.
CNTs/CNFs have the potential to function as biosensors for respiratory system pathological
diagnosis, such as their use for the detection of lung cancer. Choudary et al. [25] showed that lung
cancer antigens, MAGE A2 and MAGE A11, covalently attached to SWCNT-chitosan composites
detected anti-MAGE A2 and anti-MAGE A11, respectively. A more sophisticated application of
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CNT-based biosensors for diagnosis and detection was developed by Tian et al. [26]. Using CNTs and
hairpin sequences against a specific microRNA, Tian and coworkers showed femtomolar detection of
the lung cancer biomarker, let-7 microRNA.
These studies indicate the possible applicability of using CNTs/CNFs as bioscaffolds in
regenerative medicine and biosensors in clinical assays. Although CNTs induce toxicological responses
in the respiratory system in cellular and animal models, CNTs in combination with biopolymers
seem to have different interactions, particularly, with osteogenic or neuronal cells. Moreover, since
most of these studies were short term, it is prudent to suggest the need for long-term studies for the
applicability of CNTs/CNFs as bioscaffolds.
4. CNT Toxicological Pathways
4.1. Oxidative Stress
Oxidative stress is the most accepted mechanism for CNTs, asbestos, and other nanoparticles’
toxicity [5,27–30]. It is well established that ROS can react with cellular macromolecules and disrupt
intracellular homeostasis. For example, numerous studies have shown that the presence of transition
metals (e.g., Fe, Ni, Cu) in CNTs induces the formation of molecular oxygen-dependent superoxide
anion radicals (O2 ¨´ ), hydrogen peroxide (H2 O2 ) and hydroxyl radicals (¨HO), all of which have
high redox potentials and reactivities [29,30] (Figure 1). However, studies have also shown that even
purified MWCNTs induce cyto- and genotoxic responses in BEAS-2B bronchio-epithelial cells [31,32].
Specific molecular signaling factors associated with oxidative stress, such as activator protein-1 (AP-1),
nuclear factor κB (NF-κB), and MAP kinases ERK1/2 and p38, are activated by CNTs/CNFs and lead
to antioxidant defense mechanism depletion or downregulation [32]. In mesothelioma cells, MWCNTs
induced the formation of superoxide and DNA damage [33]. In vivo studies by Khaliullin et al. [34]
and Shvedova et al. [35] showed that MWCNTs given by aspiration or SWCNTs either administered by
pharyngeal aspiration or inhalation, decreased the level of glutathione, increased the level of protein
thiols, and increased the level of malondialdehyde (MDA). Although CNFs are similar to MWCNTs,
CNFs’ specific physicochemical characteristics, particularly having a low level of catalytic trace metals,
may or may not induce ROS. This fact still requires further toxicological experimental investigation.
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mucus production. These results suggest that other cytokines compensate for the TGFβ signaling
pathway [40,43]. TGFβ1 is a key molecule in the development and progression of pulmonary fibrosis. It
promotes the transcription of collagen type I and fibronectin in fibroblasts through an intricate signaling
cascade. Furthermore, at the cellular level, CNTs were shown to induce plasma membrane remodeling
via rearrangement of the actin cytoskeleton and clathrin [38,41]. In addition to cytokines, matrix
metalloproteinases (MMPs) play an important role in tissue remodeling; however, MMP regulation
by CNTs is less studied yet. A recent study by Meng et al. [44] showed that naïve macrophages
secreted MMP-9 and VEGF in the presence of CNTs. MMP-9 is a known key factor in TGFβ activation
and extracellular matrix remodeling in normal physiology but also in the pathophysiology of lung
disease [44]. In addition to MMP-9 production, it has been shown that long-term, i.e., 4 months,
exposure of mesothelial cells to both SWCNTs and MWCNTs increased MMP-2 expression and activity,
which was involved in cell migration and invasion [45]. Poulsen et al. [46] showed that MWCNTs of
different sizes (short: 67 ˘ 26.2 nm and long: 4.05 ˘ 2.4 µm) at either 3 days or 28 days post-exposure,
induced lung remodeling regardless of the dose (54 or 163 µg/mouse). In addition to fibrosis
genes of the MMP family (Mmp-12, Mmp-13, Mmp-14), MWCNT also upregulated the expression
of tissue inhibitors of metalloproteinase (Timp-1, Timp-2, Timp-3, Timp-4), and TFGβ receptors signaling
(Tgfbr-1, Tgfbr-3). Long MWCNTs were more potent in inducing gene expression than short MWCNTs.
MWCNTs have also been shown to induce airway tissue remodeling via cyclooxygenase-2 (COX-2).
Sayers et al. [47] showed that MWCNT potentiated allergen-induced increase in Th2, Th1, Th17
cytokines, prostaglandin D2, thromboxane B2, inflammation, and mucus-cell metaplasia in the
lungs of COX-2(-/-) mice compared to wild type mice. However, no differences in airway fibrosis
were noted between COX-2(-/-) and wild type mice. Similarly, Mizutani et al. [48] reported that
MWCNTs sensitized airways in OVA-challenged mice via airway resistance, inflammation, and
goblet cell hyperplasia, and induced a biphasic increase in airway responses and antigen-specific
antibodies. Biphasic acute airways’ responses to CNTs manifested in the form of inflammation and
inflammatory cells accumulation and chronic responses like lung fibrosis were also reported by
Mercer et al. [37,49]. Furthermore, Wang et al. [50] showed a role of IL-33 in MWNCT-induced airway
constriction, inflammation, and fibrosis. Il-33 signaling mediates allergen-induced Th2 cytokines
which induce asthma. Asthma, a chronic airway inflammation and hyper-responsiveness is a major
public health concern. Approximately 10% of the U.S. population and approximately 300 million
people worldwide are affected by asthma [51].
These studies indicate that CNTs induce airways resistance in animal models and this should be
taken into consideration as CNTs are being rapidly incorporated into numerous nanoproducts. Thus,
it is prudent to strongly suggest the adoption of strict prevention strategies and workplace exposure
controls in workplaces dedicated to CNTs/CNFs manufacture.
4.3. Genotoxicity
The potential of CNTs and CNFs to induce genetic alterations has been investigated in different
system models; most often the results were partially dependent on the type and physical characteristics
of the nanomaterial tested [52–54]. Although SWCNTs have been shown to induce genetic alterations,
no tumors have been reported in any study [55,56]. However, some MWCNTs have been shown to
induce genetic damage, but only MWCNT Mitsui 7 has been shown to induce carcinogenicity via
induction of mesothelioma (reviewed by Toyokuni, [54]). A study by Sargent and coworkers [57]
showed that MWCNTs induced genotoxicity; however in a subsequent study in [58], the same
MWCNTs did not induce tumors unless there was an initiator. The latter study is crucial to extrapolate
to human exposure, since many humans are exposed to mutagens including cigarette smoke, chemicals
such as benz[a]anthracene, radon, naphthalene, diesel exhaust benzo[a]pyrene, and others. If these
materials can serve as initiators, humans exposed to MWCNTs could develop tumors [58–60].
The potential of CNFs to cause DNA damage was initially evaluated in Chinese hamster
lung fibroblast cells, V79, using the Comet assay and micronuclei formation (MN) procedures by
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Kisin et al. [61]. In this study, CNFs induced DNA damage but no differences were found between
CNF or asbestos at similar doses (3 or 48 µg/cm2 ) and exposure times (3 or 24 h). CNF and asbestos
dose-dependently induced MN formation in V79 cells. In the same study, CNF aneugenic or clastogenic
effects were evaluated in human small airway epithelial cells (SAECs) in comparison with asbestos.
CNF increased both aneugenic and clastogenic events and could be found inside the nucleus of
SAECs. The mechanism by which CNFs induce genotoxicity is not known yet, however, direct
physical interactions of nanofibers with mitotic machinery or with chromosomes during cell division
leading to aneuploidy are possible. Aneuploidy is the result of imbalanced chromosome separation
during cell division leading to the formation of daughter cells with an abnormal chromosome number.
DNA damage and adduct formation are related to the generation of ROS via the Fenton reaction.
The presence of transition metals such as Fe in CNFs, has been found to generate ROS; therefore, the
genotoxic effects of CNF may be partially accounted for by ROS generation [61]. A major health concern
of CNFs is further supported by findings in the study by Kisin et al. [61] where CNF genotoxicity was
comparable to asbestos and CNFs were more potent than SWCNTs. In addition to ROS-mediated
DNA damage, CNTs physically interact with DNA, particularly MWCNTs which have been shown to
exhibit preference toward G-C rich DNA regions [24,62–67]. CNTs have been shown to induce DNA
strand breaks, which can either be caused by the direct effects of ROS or apoptosis, and by the activity
of endonucleases that are activated by the formation of DNA adducts [52,66]. Both SWCNTs and
MWCNTs induce DNA strand breaks, PPAR activation, and formation of γH2AX foci in lung epithelial
cells [30,31,52,57,58,66–70]. Sargent and co-authors [57,58] observed the induction of aneuploidy,
formation of three spindle poles, microtubules and centrosome fragmentation, and accumulation of
cells in the G2/M phase in SAEC exposed to a dose that would be a worker-relevant exposure dose
of SWCNTs (0.024 µg/cm2 ). Similarly, Siegrest and co-authors [67] obtained similar results when
MWCNTs were tested on the same cell type, SAECs, with the exception of the accumulation of cells in
G1/S phase rather than in the G2/M phase as was the case of SWCNTs. Mechanistically, these studies
indicate physical association of SWCNTs and MWCNTs with DNA, mitotic spindles, and centrosomes
thus impeding proper chromosome segregation.
Long-term post-exposure of mice (C57BL/6) to SWCNTs via inhalation or aspiration, and
CNFs via aspiration demonstrated that SWCNTs induced K-ras mutations regardless of the mode of
administration, whereas CNFs induced such mutations only at very high doses [56]. However, despite
oncogenic K-ras mutations, no tumors were found after one year in mice exposed to SWCNTs, CNFs, or
asbestos, regardless of the mode of administration. Furthermore, in vivo studies with MWCNT-induced
mesothelioma showed effects on gene stability (Cdkna2a/2b) and protein expression (vimentin and
podoplanin) [58,71,72].
These findings suggest that in addition to particle chemistry, other characteristics such as
physical properties, and the physiological interaction of CNTs/CNFs via administration (inhalation or
aspiration) also modulate pathological responses [56]. However, these studies clearly indicate that
although CNTs/CNFs induce genotoxic insults, no tumors were initiated in the animals unless there
was an initiator, thus these findings should be taken with prudence.
4.4. MicroRNA Regulation
The role of microRNA in mediating molecular carbon-based nanoparticles toxicity is relatively
unknown. microRNAs are short noncoding RNA strands that regulate post-transcriptional gene
expression in plants, animals, and humans [73]. The relationship between MWCNTs and microRNA
was first studied by Zhao et al. [74]. In this study, the authors exposed Caenorhabditis elegans (CE)
to different concentrations of MWCNTs (0.1, 1, and 10 mg/L) and identified microRNA targets
for MWCNTs using next-generation sequencing analysis. MWCNTs differentially dysregulated
55 microRNAs, of which 21 were up-regulated and 34 down-regulated. Using a prediction approach,
the MWCNT-dysregulated microRNAs were mainly targeting genes involved in biological processes
associated with development, cell adhesion, cell cycle, and immune response. The functional
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relationship between dysregulated microRNAs and MWCNT toxicity was also studied using a
gain-of-function approach. Gain-of-function of microRNA-51 resulted in resistance to MWCNT
toxicity whereas loss-of-function of microRNA-259 resulted in susceptibility of MWCNT toxicity.
Although no specific mRNA targets for these dysregulated microRNAs were identified in the study,
the data suggests that human exposure to MWCNTs could have complex effects on gene expression.
Similarly, Nymark et al. [75] showed that exposure of BEAS-2B cells to MWCNTs lead to mitochondrial
membrane potential (MtMP) dysfunction, regulation of over 300 genes of which 26 genes were linked
to mitochondrial function, and a small microRNA signature. Of the four microRNAs signatures,
miR-1275 negatively correlated with MtMP-dysfunction genes. These studies show that microRNA
are involved in regulating CNT toxicity and in vivo translocation, and may be useful in circumventing
CNTs toxicity for potential biological uses.
5. CNT-Induced Toxicological and Pathological Responses
5.1. Airway Hypersensitivity
Ultrafine particles including CNTs have been shown to induce allergic responses in several
experimental model systems [76,77]. Intratracheal instillation of MWCNTs caused an allergic response
in mice with increased populations of B-cells in the spleen and blood, and increased levels of
Th2-cytokines (IL-4, Il-5, IL-10) and IgE [78]. MWCNT also aggravated allergic airway inflammation
via infiltration of inflammatory cells and antigen presenting cells in the bronchial epithelium; increased
Th cytokines/chemokines; and increased IgG1 and IgE levels [79]. Another study by Rydman et al. [80]
found that in short term inhalation of two types of MWCNTs (rod-like rigid and flexible tangled)
only the rigid type induced allergic-like-airway responses marked by increased eosinophil infiltration,
mucus hypersecretion, and Th2 cytokines expression. Intratracheal administration of SWCNTs with
an allergen to mice exacerbated Th2 cytokine levels in the lungs and increased IgG1 and IgE in the
serum [81,82]. In a mouse model of asthma, MWCNTs induced an influx of inflammatory cells,
increased mucus and IgG1 production, and increased the activation of inflammatory genes IL-13, Il-25,
IL-33 and GM-CSF [43].
Investigations comparing the effects of CNFs and CNTs on airway hypersensitivity showed
that CNFs increased adjuvant-mediated IgE production, whereas CNTs (SWCNTs and MWCNTs)
increased IgE production and eosinophil recruitment to the lungs [83]. In this study, the authors
showed that some of the CNFs had high Ni levels, but induced a medium allergic response as opposed
to MWCNTs which were low in Ni, but powerful in inducing allergic responses. A more recent
study by Thompson et al. [40] showed a differential activation of white blood cells (WBCs) in a
murine-model of allergen-induced airways remodeling. Ovalbumin (OVA) alone increased the number
of eosinophils while the addition of MWCNTs increased only neutrophil numbers in bronchoalveolar
lavage. Mechanistically, these authors showed a role of STAT1 in MWCNT-induced airway remodeling
via IL-13. MWCNTs increased goblet cells hyperplasia and airway fibrosis in mice bearing a deletion
of STAT1 and OVA-sensitized mice. Molecularly, MWCNTs increased IL-13, TGFβ, and TNFα; and
decreased IL-10 [40]. These studies clearly show the potency of CNTs over CNFs in inducing allergic
responses, mostly due to their structure rather than due to metallic contaminants [83].
5.2. Inflammatory Responses
Acute and chronic inflammatory responses to CNTs have been documented in numerous in vitro
and in vivo studies [35,40,84–88]. In vivo inflammatory responses were primarily characterized by the
recruitment of lymphoid cells into the bronchial epithelium, lung parenchyma, and lung perivascular
tissue [35,56,89,90]. Regardless of the mode of administration (e.g., inhalation, instillation, intratracheal
instillation), MWCNTs induced the recruitment of eosinophils, neutrophils, macrophages, and
antigen-activated dendritic or goblet cells [10,39]. Poulsen et al. [46] showed that MWCNTs induced
the activation of inflammatory genes TNFα, CCL and CXCL chemokines, and increased the levels of
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serine protease inhibitors (SERPINs), serum amyloid A3, TNFα, and Il-1β regardless of their physical
size (short or long).
5.3. Fibrogenic Responses
Numerous studies have demonstrated the fibrogenic potential of CNTs either in in vitro or in vivo
models (Figure 1) [37,46,84,91,92]. Although particle settlement in the lungs is partly determined by
physical properties, i.e., diameter and length, studies have shown that SWCNTs possess a greater
fibrotic potential than MWCNTs [37,92]. However, Mercer et al. [37] showed that MWCNTs with a mean
size of 3.9 µm ˆ 49 nm deposited at approximately 8% in the alveolar septa at 56 days post-exposure
and progressively increased collagen deposition in the lungs over a period of 11 months [37,49].
Long term post-exposure studies of CNTs showed the presence of MWCNTs in the lung interstitium;
however, most of the MWCNTs were of small size and seemed to be less potent in inducing lung
fibrosis than SWCNTs [37,39,56].
5.4. Tumorigenic Responses
Whether CNTs stimulate the growth of lung tumors still remains unknown; however, several
studies suggest that CNTs may act as tumor promoter. Shvedova et al. [10,35] showed that one single
acute exposure to SWCNTs resulted in lung tumor burden but was conditional on SWCNTs interactions
with myeloid-derived suppressor cells (MDSCs) and TGFβ production. Studies investigating
the tumorigenic effects of MWCNTs showed no lung cancer but mesothelioma, which at times
was dependent on the type of MWCNTs involved (Figure 1). Muller et al. [88] reported that
short MWCNTs (<1 µM) administered intraperitoneally did not induce mesothelioma. Similarly,
Nagai et al. [88,93] reported no mesothelioma following thick or tangled MWCNTs (diameter: 150
and 15 nm) administration, but mesothelioma with thin MWCNTs (diameter 50 nm) intraperitoneally
administered to rats. Takagi et al. [94] showed the induction of mesothelioma in p53-deficient mice.
Sargent et al. [58] showed that inhalation of MWCNTs (Mitsui-7) induced lung neoplasms in mice
only if mice were pretreated with the neoplasm initiator methylcholanthrene (MCA). However, mice
exposed to MCA followed by MWCNTs inhalation developed malignant sarcomatoid mesotheliomas
morphologically appearing as nodular masses composed of polygonal to spindloid cells in the
diaphragm [58].
To further investigate the tumorigenic mechanism of CNTs, Luanpitpong et al. [95,96] showed
that chronic exposure of human lung cells to SWCNTs for 6 months induced the appearance of cancer
stem cells-like cells, which when implanted in mice promoted tumor development. The mechanism by
which SWCNTs promoted the formation of cancer stem cells-like cells was partly via p53 inactivation
and caveolin-1 over-expression [97].
6. Human Exposure to CNTs/CNFs
Few studies have reported human exposure to CNTs/CNFs. In 2012, Dahm et al. [97] measured
exposure levels to CNTs/CNFs at six primary and secondary manufacturing sites. Using personal
breathing area and area sampling the authors found most of the collected samples were below the REL
(7 µg/m3 ) and only two tested sites had higher exposure limits than REL. The 7 µg/m3 REL was the
initial exposure level set by NIOSH in 2010 [98].
The actual effect of MWCNTs on human health was first presented by Lee et al. [99] for a U.S.
MWCNTs manufacturing site. The authors surveyed workers’ health in a workplace where MWCNTs
are manufactured. A higher level of elemental carbon was found in the personal worker area than in
the sampling area (6.2–9.3 µg/m3 and 5.5–7.3 µg/m3 , respectively). The exhaled breath condensate
of manufacturing workers contained higher levels of oxidative stress markers (MDA, 4-HHE, and
n-hexanal) and higher blood molybdenum than office workers. The levels of CNTs/CNFs in the
personal breathing area of workers were found to be above the proposed recommended exposure
limits in secondary manufacturing sites that use the nanoparticles for commercial applications [99].
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Kuijpers et al. [100] assessed occupational exposure of workers to MWCNTs during production and
handling at a commercial facility in The Netherlands. The authors reported that in the production
and handling areas, the exposure levels to MWCNTs were similar at 41 and 43 µg/m3 respectively,
whereas in the research and development area (R&D) and the office area, exposure levels of MWCNTs
were at 5 and 7 µg/m3 , respectively. However, in 2013 The U.S. agency NIOSH has recommended an
occupational exposure limit (REL) of 1 µg/m3 CNT which initially was set at 7 µg/m3 [101] for an
8 h time-weighted average of elemental carbon EC, the respirable fraction of CNT. Although, in the
above studies, the exposure level of MWCNTs was much higher than the REL, neither study indicates
whether the workers were wearing personal protective equipment. Han et al. [102] showed that use
of engineering controls effectively decreases airbone MWCNTs during synthesis and processing in a
laboratory setting. Methner [103] showed that local exhaust ventilation decreased MWNCTs during
reactor cleaning by 88%, and Regasamy et al. [104] showed that face respirators with 95 or 100 series
filters effectively captured 95% of nanoparticles 4–30 nm in size.
7. Conclusions and Perspectives on CNTs
In summary, the experimental data presented in this review clearly shows that CNTs/CNFs
induce respiratory pathologies in animal models, although some studies (a few) report negative results
(Figure 1 and Table 1), and that CNTs/CNFs are released during production and handling. Moreover
numerous studies conducted over the past two decades since the discovery of CNTs in 1991 have
provided a wealth of scientific knowledge on CNT/CNF interactions with biological systems and
have contributed to development of methods of handling, limits of exposure, and toxicity outcomes,
and importantly classification of one type of MWCNTs as carcinogen. Among the different types of
MWCNTs presented in this article, based on the experimental data, MWCNT Mitsui 7 is classified as a
carcinogen [105,106].
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Table 1. List of some of the in vivo studies which show CNTs/CNFs toxicity on the respiratory system.
Year

Types of CNTs/Sources

CNTs Length

Assay Type

<1 µm

Wistar rats

Mode of Administration

Dose

Exposure Time

2, 20 mg/animal

24 months

Outcome

Reference

MWCNTs negative results
2009

2010

MWCNT +/´ defects
MWCNT (MWNT-7, Lot
# T050831-01, Mitsui & Co. Ltd.
9, Tokyo, Japan)

1.5 µm

SD rats

I.P.

I.T.

0.04, 0.2, 1 mg/kg

3, 7 days; 1, 3, 6
months

No mesothelioma

[88]

Negative interstitial tissue,
absence of fibrosis,
MWCNT + Macrophages in
alveoli. Lower case
for macrophages.

[107]

MWCNTs positive results

2004

CNT (Raw and Purified HiPco
NTs, Rice University, Huston,
TX, USA); CNT (CaboLex Inc.,
Lexington, KY, USA)

<1 µm

mice

I.T.

0.1, 0.5 mg/animal

7, 90 days

Epitheloid granulomas,
interstitial inflammation, lung
necrosis; high dose induced
60% death

[89]

2009

MWCNT (Bussan Nanotech
Research, Ibaraki, Japan); SES
Research (TX, USA)

3–30 µm,
several µm

ICR mice

I.T.

25, 50 µg

6 weeks

Exacerbation of allergic murine
airway inflammation

[79]

2012

MWCNT (Mitsui MWCNT-7,
No. 060125-01k, Tokyo, Japan)

<5 µm

p53 +/´ mice

I.P.

0.3 mg/animal

1 year

Mesothelioma

[94]

2013

MWCNT (MWCNT-7, lot
# 06122031, Hodogaya, Japan)

C57BL6J

Inhal.

5 mg/m3 , 5 h/d,
4 d/wk, 12 d

1, 14, 84, 168,
336 days

Pulmonary inflammation,
progressive collagen in alveolar
regions after 336 days

[49]

2013

CNF (Statoil and Elkem Carbon
AS, Kristiansand, Norway)
SWCNT (Sigma Aldrich,
St. Louis, MO, USA, Cat.
# 636797);
MWCNT (Sigma-Aldrich,
St. Louis, MO, USA, Cat.
# 636487)

5–10
0.5–100
0.5–200 µm

BALB/cAnNCrl
Mice

Intra-nasal

400 µg/mouse

26 days

Modulation of airway responses
to allergens; CNT more potent
than CNF

[83]

2014

MWCNT (Mitsui-7, MWNT-7,
lot #061220-31, Hodogaya,
Japan) MCA, MWCNT,
MCA + MWCNT

0.5–5 µm

B6C3F1

Inhal.

5 mg/m3 , 5 h/d,
5 d/wk, 15 d

17 months

MCA potentiated MWCNT
adenocarcinoma MWCNT alone
did not induce adenocarcinoma

[58]

2015

MWCNT

5.53–6.19 µm

F344 rats

Inhal.

0.2, 1, 5 mg/m3

13 weeks

granulomatousa in females at 1
and 5 mg/m3 ; in males at
0.2 mg/m3 fibrosis

[108]

2015

MWCNT CNTsmall (NC700,
Nanocyl, Sambreville, Belgium;
13% impurities); CNTlarge
(NM-401, European Joint
Research Centre, Ispra, Italy;
3% impurities)

0.85, 4.05 µm

C57BL/6 mice,
female

I.T.

18, 54, 162
µg/animal

1, 3, 28 days

Similar inflammatory and acute
responses to both types;
stronger fibrotic response to
CNTlarge than CNTsmall

[46]
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Table 1. Cont.
Year

Types of CNTs/Sources

CNTs Length

Assay Type

Mode of Administration

Dose

Exposure Time

Outcome

Reference

T.

50 µg

6 weeks

Exacerbation of allergic murine
airway inflammation

[82]

Pharyngeal aspiration,
inhalation

40 µg/animal
40, 120 µg/animal
120 µg/animal
5 mg/m3 ,
5 h/4 d

1 year

All particles induced chronic
bronchopneumonia, pulmonary
fibrosis. CNF > asbestos >
SWCNT inflammation, SWCNT
were the most fibrogenic, CNF,
SWCNT induced K-ras
mutations, No tumors

[56]

1, 3, 7, 30, 90 days

Lung focal inflammation,
neutrophil in alveoli, lung
macrophages and cell derby in
alveoli, higher CNT burden in
CNT-1 than CNT-2 at 90 days

[109]

SWCNTs positive results
2010

SWCNT: CNI, (USA); SES Res.
(USA)

2014

SWCNT (HiPco, Unidym,
Sunnyvale, CA, USA);
CNF (Pyrograf Prod., USA)
Asbestos (UICC, USA)

2015

SWCNTs (Tech. Res. Assoc. for
SWCNT, Japan)

1–15 µm

1–3 µm,
5–30 µm,
2–30 µm

CNT-1 (0.51 µm,
short);
CNT-2 (1.67 µm,
long/thick)

ICR mice

C57BL/6 mice

Wistar rats

I.T.

0.18, 1.8 mg/kg

CNTs, carbon nanotubes; CNFs, carbon nanofiber; IT, intratracheal instillation; Inhal, inhalation; IP, intraperitoneal; MCA, methylcholanthrene.
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With regards to the carcinogenicity of CNTs/CNFs, there are no studies which show that chronic
exposure to CNTs/CNFs leads to the development of lung cancer. Two studies, Shvedova et al. [56]
and Sargent et al. [58] show the absence of lung tumors induced only by CNTs/CNFs (Table 1).
However, the study by Sargent et al. [58] clearly shows that if a tumor is initiated, MWCNTs
promote lung adenocarcinoma. This study is most likely to reflect humans, since people smoke
or have genetic predisposition, etc., thus in such situations, CNTs may accelerate tumor progression.
This is also supported by numerous in vitro studies which point out that CNTs activate molecular
mechanisms associated with tumorigenesis and since typical fiber-induced lung cancer in humans
is 30–40 years, it is prudent to advise the adoption of strategies and implementation of exposure
controls in environments where CNTs/CNFs are present. Given that the production and applications
of CNT-based nanoproducts will likely increase and thus the presence of CNTs in the environment
either from product wear, disposal, or manufacturing will likely increase. Therefore, CNTs might
become more bioavailable andthis could enhance the potential for adverse respiratory effects. Since
many chronic lung diseases, i.e., fibrosis and chronic obstructive pulmonary disease (COPD), are
time-dependent, novel and innovative approaches to circumvent the advent of CNT accumulation
in the environment need to be considered. Just as the studies by Martino et al. [110] and
Favero-Longo et al. [111] showed that soil fungi and lichens were detoxifiers of asbestos via chelation
or removal of reactive metal iron, the scientific community must envision the development of novel
protocols leading to nanobioremediation. For example, Yang et al. [112] developed a chemical
approach based on the use of Ca2+ and paper filtration to extract CNTs from an aqueous environment,
while Zhang et al. [113] showed that pristine or oxidized (O´ ) MWCNTs at low doses enhanced
bacterial growth and biodegradation of organic molecules in an aqueous environment; however, high
doses inhibited bacterial growth. In addition to nanobioremediation, the use of CNTs to increase
microalgae biomass for sustainable energy production has also been proposed [114]. Based on the
history of asbestos and its human health effects, the scientific community may explore the use of
procedures developed for other environmental contaminants, such as asbestos, as a guide to more safely
produce and process nanomaterials [115]. Although asbestos has been banned in the USA and other
countries, it still remains an environmental hazard. Consequently, research is still being conducted to
develop methods to reduce asbestos contamination. We can potentially use this knowledge to design
and post-process CNTs as a preemptive approach to minimizing nanodiseases and to avoid future
asbestos-like phenomena.
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